Study on efficacy and safety of transcatheter arterial chemoembolization (TACE) combined with regorafenib and PD-1 antibody versus continued TACE combined with regorafenib in patients with hepatocellular carcinoma after failed second-line treatment with regorafenib

Haochen Wang, Weizhong Xiao, Yanjing Han, Shasha Cao, Zhiyuan Zhang, Guang Chen, Yuefeng Hu, Long Jin